About
Adrienne Graves joined Iveric Bio as Board Of Directors in 2018.Adrienne L. Graves, Ph.D. is a visual scientist by training and a global industry leader in ophthalmology. From 2002 to 2010, Dr. Graves was President and Chief Executive Officer of Santen Inc., the US arm of Japan's largest ophthalmic pharmaceutical company. She joined Santen in 1995 as VP of Clinical Affairs to initiate clinical development in the US, and was responsible for 3 NDA approvals. She was promoted to Sr. VP of Worldwide Clinical Affairs (Japan, US, and Europe), and was subsequently named a global Corporate Officer and CEO of US operations. Prior to joining Santen, Dr. Graves spent nine years with Alcon Laboratories, Inc., beginning in 1986 as a Senior Scientist. She progressed through various roles, including Director of International Ophthalmology. Dr. Graves currently serves as an Independent Director on the following corporate boards: Akorn, Inc., TearLab Corporation, Aerpio, and Encore Vision. She
Position in the VCSift Database
- • 23 investors hold the Independent Director role in VCSift. Adrienne L. Graves is one of them.
- • 295 investors are based in Raleigh, North Carolina, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Raleigh, US
Contact Information
Find more investors like Adrienne
Search Investors